共 50 条
- [41] LONG-TERM FOLLOW-UP OF PATIENTS WHO RECEIVED 10,098 SPINAL ANESTHETICS .4. NEUROLOGICAL DISEASE INCIDENT TO TRAUMATIC LUMBAR PUNCTURE DURING SPINAL ANESTHESIAJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1960, 172 (14): : 1483 - 1487VANDAM, LDDRIPPS, RD
- [42] Estimating long-term survival of previously untreated patients with EGFR mutation-positive (EGFRm) advanced non-small cell lung cancer (NSCLC) who received osimertinib in the FLAURA study.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)Dyer, MatthewGreen, MatthewJones, SimonHodge, Rachel
- [43] Long-term survival results of a randomized multinational phase 3 trial of dacarbazine (OTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM).JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 711S - 711SKirkwood, JMBedikian, AYMillward, MJConry, RMGore, MEPehamberger, HESterry, WPavlick, ACDeconti, RCItri, LM
- [44] Randomized multinational phase 3 trial of dacarbazine (DTIC) with or without Bcl-2 antisense (oblimersen sodium) in patients (pts) with advanced malignant melanoma (MM): Analysis of long-term survival.JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 711S - 711SMillward, MJBedikian, AYConry, RMGore, MEPehamberger, HESterry, WPavlick, ACDe Conti, RCGordon, DItri, LM
- [45] LONG-TERM SURVIVAL OF IPILIMUMAB-NAIVE PATIENTS WITH ADVANCED MELANOMA (MEL) TREATED WITH NIVOLUMAB (ANTI-PROGRAMMED DEATH-1; ANTI-PD-1; BMS-936558; ONO-4538) IN A PHASE I TRIALASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 177 - 177Hodi, StephenSznol, MarioKluger, Harriet M.McDermott, David F.Carvajal, Richard D.Lawrence, Donald P.Topalian, Suzanne L.Atkins, Michael B.Powderly, John D.Sharfman, William H.Puzanov, IgorSmith, David C.Leming, Philip D.Lipson, Evan J.Taube, Janis M.Anders, Robert A.Horak, Christine E.Kollia, GeorgiaGupta, AshokSosman, Jeffrey A.
- [46] Design of an ongoing randomized study on the long-term safety and efficacy of darbepoetin alfa (DA) administered 500 mcg every three weeks (Q3W) to non-small cell lung cancer (NSCLC) patients (pts) with anemia concomitant with chemotherapy (ACC)JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)Gascon, P.Henry, D. H.Fleishman, A.Borenstein, J. E.
- [47] Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitorsBMC Surgery, 23Tianyu JiaoHaowen TangWenwen ZhangBingyang HuTao WanYinbiao CaoZe ZhangYafei WangJunning CaoMengqiu CuiShichun Lu
- [48] Long-term survival and portal vein patency with novel PVTT surgery approach in advanced HCC patients with Vp3/4 PVTT following combination therapy of TKIs and PD-1 inhibitorsBMC SURGERY, 2023, 23 (01)Jiao, TianyuTang, HaowenZhang, WenwenHu, BingyangWan, TaoCao, YinbiaoZhang, ZeWang, YafeiCao, JunningCui, MengqiuLu, Shichun
- [49] Design and rationale of a double-blind, randomized, placebo-controlled study to evaluate the long-term safety and efficacy of darbepoetin alfa administered 500mcg once every three weeks (Q3W) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving multi-cycle chemotherapyJOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S431 - S431Markus, RichardHenry, DavidGascon, PereFleishman, AlexBorenstein, Jeff
- [50] Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter studySLEEP, 2008, 31 (01) : 79 - 90Krystal, Andrew D.Erman, MiltonZammit, Gary K.Soubrane, C.Roth, Thomas